Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
IF: 2.9 5-Year IF: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN Print: 0743-4863
ISSN Online: 2162-660X

Volume 37, 2020 Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i1.20
46 pages

Drug Delivery to the Nasal Cavity: In Vitro and In Vivo Assessment

Stephen P. Newman
Pharmaceutical Profiles Ltd., Mere Way, Ruddington Fıelds, Nottingham NG11 6JS, UK
Gary R. Pitcairn
Pharmaceutical Profiles Ltd., Nottingham, UK
Richard N. Dalby
University of Maryland School of Pharmacy, Baltimore, Maryland, USA


Drugs are given intranasally for both local and systemic applications, and the use of the intranasal route is predicted to rise dramatically in the next 10 years. Nasal drug delivery may be assessed by a variety of means, but high reliance is often placed upon in vitro testing methodology (emitted dose, droplet or particle size distribution, spray pattern, and plume geometry). Spray pattern and plume geometry define the shape of the expanding aerosol cloud, while droplet size determines the likelihood of deposition within the nasal cavity by inertial impaction. Current FDA guidance recommends these methods as a means of documenting bioavailability (BA) and bioequivalence (BE) for topically acting solution formulations, because they can be performed reproducibly and are more discriminating among products. Nasal drug delivery in vivo may be determined by several radionuclide imaging methods: the two-dimensional imaging technique of gamma scintigraphy has been used most widely, but the three-dimensional method of positron emission tomography (PET) is being used increasingly often. In some situations a good in vitro/in vivo correlation (IVIVC) exists; for instance, negligible penetration into the lungs has been demonstrated in the case of nasal pump sprays delivering large droplets, while a clear difference may be shown in intranasal deposition between two aerosols with markedly different size distributions. However, recent studies have shown a poorer IVIVC for two similar nasal pump sprays, where significant differences in in vitro parameters were not reflected in differences in nasal deposition in vivo. It is suggested that radionuclide imaging data may have an important role to play as an adjunct to in vitro testing in BA and BE assessments and may provide a clearer understanding of the changes in in vitro parameters that are important for predicting differences in in vivo performance.

Articles with similar content:

Atomization and Sprays, Vol.11, 2001, issue 6
Ilia V. Roisman, Cameron Tropea
Colloidal Drug Delivery Systems: Current Status and Future Directions
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 2
Goutam Rath, Tarun Garg, Amit Kumar Goyal
Mechanisms of Stem Subsidence in Femoral Impaction Allografting
Critical Reviews™ in Biomedical Engineering, Vol.39, 2011, issue 6
Goran Fernlund, Hanspeter Frei, Carolyne Albert, Clive Duncan
Implant Debris Particle Size Affects Serum Protein Adsorption Which May Contribute to Particle Size-Based Bioreactivity Differences
Journal of Long-Term Effects of Medical Implants, Vol.24, 2014, issue 1
Anand Reddy, Marco S. Caicedo, Joshua J. Jacobs, Nadim James Hallab, Lauryn Samelko
Polymeric Immunonanoparticles Mediated Cancer Therapy: Versatile Nanocarriers for Cell-Specific Cargo Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 1
Niyati S. Acharya, Namdev L. Dhas, Ritu R. Kudarha, Sanjeev R. Acharya